MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Subthalamic nucleus(SIN)"

  • 2016 International Congress

    Electrophysiological activity of anatomically identified STN subterritories in Parkinson’s disease

    N.G. Pozzi, G. Arnulfo, F. Steigerwald, A. Canessa, R. Nickl, C. Matthies, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

    Objective: To characterize the electrophysiological activity of the subthalamic nucleus (STN) functional subterritories, as anatomically defined on fused CT/MRI images or by the recording tract…
  • 2016 International Congress

    AntiParkinsonian medication adjustments following deep brain stimulation of subthalamic nucleus in patients with advanced Parkinson’s disease

    A. Gamaleya, E. Bril, A. Tomskiy, A. Poddubskaya, N. Gubareva, N. Fedorova, V. Shabalov (Moscow, Russia)

    Objective: We aimed to evaluate the long-term changes in medication of patients with advanced Parkinson's disease (PD) following STN-DBS in our center. Background: Usually antiParkinsonian…
  • 2016 International Congress

    EARLYSTIM: STN-DBS alleviates behavioural side effects of dopamine replacement therapy when compared to best medical treatment

    E. Lhommée, W. Lars, C. Virginie, K. Witt, F. Maier, L. Tonder, L. Timmermann, T. Hälbig, F. Pineau, F. Durif, T. Witjas, J.L. Houeto, P. Krack (Grenoble, France)

    Objective: To compare effects of STN-DBS and dopamine replacement therapy (DRT) on behaviour in PD in a 2 year follow-up study. Background: A large panel…
  • 2016 International Congress

    Subthalamic deep brain stimulation vs. intraduodenal levodopa infusion: A long-term retrospective comparative study

    A. Merola, A.J. Espay, A. Romagnolo, A. Bernardini, M. Rosso, K.J. Espay, L. Rizzi, M. Zibetti, M. Lanotte, L. Lopiano (Torino, Italy)

    Objective: To analyze the long-term retrospective data of patients treated with Levodopa/carbidopa intestinal gel infusion (LCIG) and subthalamic nucleus deep brain stimulation (STN-DBS) in two…
  • 2016 International Congress

    Comparison of effect of variable deep brain stimulation (DBS) frequencies on gait and balance in Parkinson’s disease (PD) patients with either bilateral GPi or STN stimulators employing wearable wireless sensors

    A. Deep, A. Lieberman, R. Dhall, T. Lockhart, C. Frames, S. Shafer, N. Tateuchi, E. Simpson, M. McCauley, N. Krishnamurthi (Phoenix, AZ, USA)

    Objective: To compare the effect of variable Deep brain Stimulation (DBS) frequencies on gait and balance in Parkinson's disease (PD) patients with either bilateral GPi…
  • 2016 International Congress

    DTI tractographic correlates of weight gain in Parkinson’s disease patients after STN DBS

    O.F. Ahmad, L. Huang, N. Vanegas-Arroyave, K. Zaghloul, S.G. Horovitz, C. Lungu (Bethesda, MD, USA)

    Objective: To assess DTI connectivity patterns and correlations with weight gain in Parkinson's disease patients after STN DBS. Background: Weight gain is a well-known adverse…
  • 2016 International Congress

    Recent result of indicative evaluation for deep brain stimulation of Parkinson’s disease patients

    H. Saiki, S. Matsumoto (Osaka, Japan)

    Objective: To report recent result of indicative evaluation for deep brain stimulation (DBS) of Parkinson's disease (PD) patients, ant to investigate relationship between pathological condition…
  • 2016 International Congress

    VANTAGE trial: Three year outcomes of a prospective, multi-center trial evaluating deep brain stimulation with a new multiple-source, constant-current rechargeable system in Parkinson’s disease

    L. Timmerman, R. Jain, L. Chen, T. Brucke, F. Seijo, E. Suarez San Martin, C. Haegelen, M. Verin, V. Visser-Vandewalle, M.T. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Cologne, Germany)

    Objective: The VANTAGE study assesses motor improvement in moderate-to-severe Parkinson's disease (PD) following bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) using a new, implantable,…
  • 2016 International Congress

    Effect of bilateral subthalamic nuclei deep brain stimulation on impulse control disorders in PD

    R. Borgohain, P.K. Pesala, R.K. Mridula, A.K. Puligopu, V.V.P. Kagita, S.A. Jabeen, M.A. Kanikannan (Hyderabad, India)

    Objective: To study the effects of bilateral subthalamic nuclei stimulation on impulse control disorders(ICDs) in Parkinson's disease (PD). Background: Impulse control disorders(ICDs) cause significant morbidity…
  • 2016 International Congress

    The subthalamic nucleus activity during gait in Parkinson’s disease

    A. Leporini, G. Arnulfo, N.G. Pozzi, C. Palmisano, J. Brumberg, A. Canessa, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

    Objective: To investigate the activity of the subthalamic nucleus (STN) during gait in subjects with Parkinson's disease (PD). Background: Gait disturbance is a key component…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley